» Articles » PMID: 35205767

Bacterial Involvement in Progression and Metastasis of Colorectal Neoplasia

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2022 Feb 25
PMID 35205767
Authors
Affiliations
Soon will be listed here.
Abstract

While the gut microbiome is composed of numerous bacteria, specific bacteria within the gut may play a significant role in carcinogenesis, progression, and metastasis of colorectal carcinoma (CRC). Certain microbial species are known to be associated with specific cancers; however, the interrelationship between bacteria and metastasis is still enigmatic. Mounting evidence suggests that bacteria participate in cancer organotropism during solid tumor metastasis. A critical review of the literature was conducted to better characterize what is known about bacteria populating a distant site and whether a tumor depends upon the same microenvironment during or after metastasis. The processes of carcinogenesis, tumor growth and metastatic spread in the setting of bacterial infection were examined in detail. The literature was scrutinized to discover the role of the lymphatic and venous systems in tumor metastasis and how microbes affect these processes. Some bacteria have a potent ability to enhance epithelial-mesenchymal transition, a critical step in the metastatic cascade. Bacteria also can modify the microenvironment and the local immune profile at a metastatic site. Early targeted antibiotic therapy should be further investigated as a measure to prevent metastatic spread in the setting of bacterial infection.

Citing Articles

Role of human microbiota in facilitating the metastatic journey of cancer cells.

Shah H, Patel P, Nath A, Shah U, Sarkar R Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 40072555 DOI: 10.1007/s00210-025-03957-8.


Crosstalk between gut microbiotas and fatty acid metabolism in colorectal cancer.

Zhang H, Tian Y, Xu C, Chen M, Xiang Z, Gu L Cell Death Discov. 2025; 11(1):78.

PMID: 40011436 PMC: 11865559. DOI: 10.1038/s41420-025-02364-5.


Role of ursolic acid in preventing gastrointestinal cancer: recent trends and future perspectives.

Chauhan A, Pathak V, Yadav M, Chauhan R, Babu N, Chowdhary M Front Pharmacol. 2024; 15:1405497.

PMID: 39114347 PMC: 11303223. DOI: 10.3389/fphar.2024.1405497.


-induced imbalance in microbiome-derived butyric acid levels promotes the occurrence and development of colorectal cancer.

Wu Q, Fang X, Wan X, Ding Q, Zhang Y, Ji L World J Gastroenterol. 2024; 30(14):2018-2037.

PMID: 38681125 PMC: 11045493. DOI: 10.3748/wjg.v30.i14.2018.


Role of imbalanced gut microbiota in promoting CRC metastasis: from theory to clinical application.

Fan S, Zhou L, Zhang W, Wang D, Tang D Cell Commun Signal. 2024; 22(1):232.

PMID: 38637851 PMC: 11025274. DOI: 10.1186/s12964-024-01615-9.


References
1.
Shi Z, Ding H, Shen Q, Lu X, Chen J, Chen X . The clinical manifestation, survival outcome and predictive prognostic factors of 137 patients with primary gastrointestinal lymphoma (PGIL): Strobe compliant. Medicine (Baltimore). 2018; 97(1):e9583. PMC: 5943112. DOI: 10.1097/MD.0000000000009583. View

2.
Hall C, Valad L, Lucci A . Circulating Tumor Cells in Breast Cancer Patients. Crit Rev Oncog. 2016; 21(1-2):125-39. DOI: 10.1615/CritRevOncog.2016016120. View

3.
Abd-El-Raouf R, Ouf S, Gabr M, Zakaria M, El-Yasergy K, Ali-El-Dein B . Escherichia coli foster bladder cancer cell line progression via epithelial mesenchymal transition, stemness and metabolic reprogramming. Sci Rep. 2020; 10(1):18024. PMC: 7581527. DOI: 10.1038/s41598-020-74390-5. View

4.
Faraj W, El-Kehdy J, El Nounou G, Deeba S, Fakih H, Jabbour M . Liver resection for metastatic colorectal leiomyosarcoma: a single center experience. J Gastrointest Oncol. 2015; 6(5):E70-6. PMC: 4570914. DOI: 10.3978/j.issn.2078-6891.2015.044. View

5.
Cullinane C, Earley H, Tormey S . Deadly combination: and colorectal malignancy. BMJ Case Rep. 2017; 2017. PMC: 5720338. DOI: 10.1136/bcr-2017-222759. View